Targeted nanocarriers for mitogen‐activated protein kinase inhibitor delivery to treat coronary artery spasm

Author:

Li Ke12,Wang Lin3,Xu Cangbao1,Zhang Yaping1,Cheng Fan4,Shao Lingqiao4,Jia Min1,Li Xueping5,Zhan Wenhua67

Affiliation:

1. Shaanxi Key Laboratory of Ischemic Cardiovascular DiseaseShaanxi Key Laboratory of Brain DisordersInstitute of Basic and Translational MedicineXi'an Medical UniversityXi'an710021People's Republic of China

2. Shaanxi Provincial Research Center for the Project of Prevention and Treatment of Respiratory DiseasesCollege of Clinical MedicineXi'an Medical UniversityXi'an710021People's Republic of China

3. Prenatal Diagnosis CenterNorthwest Women and Childrens HospitalXi'an710061People's Republic of China

4. Department of Basic Medical ScienceXi'an Medical UniversityXi'an710021People's Republic of China

5. College of Clinical MedicineXi'an Medical UniversityXi'an710021People's Republic of China

6. Department of RadiotherapyGeneral Hospital of Ningxia Medical UniversityYinchuan750004People's Republic of China

7. Key Laboratory of Biomedical Information Engineering of Education MinistrySchool of Life Science and TechnologyXi'an Jiaotong UniversityXi'an710049People's Republic of China

Publisher

Institution of Engineering and Technology (IET)

Subject

Condensed Matter Physics,General Materials Science,Biomedical Engineering,Bioengineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3